Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of acyclovir-melissa nanofiber patch in treatment of recurrent herpes labialis
IRCT20141124020073N3Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Sep 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of aciclovir and melissa officinalis in herpes labialis, sponsored by Isfahan University of Medical Sciences. Started Sep 2021; status: completed.
02
Drugs
aciclovirmelissa officinalis
03
Conditions
herpes labialis
Beyond the preview
Go deeper on IRCT20141124020073N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141124020073N3.